The expression of the TM6SF2 protein is markedly decreased in the livers of patients with NAFLD compared to that in normal people, and TM6SF2 immunoreactivity is decreased in people with at least one copy of the T allele [52]. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.